Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).

Khasraw, Mustafa; Mukaro, Violet Rudo; West, Linda; Brandt, Conrad; Woollett, Anne Maree; Edwards, Michelle; Spokes, Robert; Mitchell, Gregory; Prince, Kimberley; Hayes, Theresa M; Collins, Ian; Guminski, Alexander David; Baron-Hay, Sally E; Olesen, Inger Helen; Bryan, Jacinta; Bowles, Susan; Wong, Shu Fen; Ashley, David M; Patil, Sujata

Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).

conference contribution

posted on 2024-06-04, 12:19 authored by Mustafa Khasraw, Violet Rudo Mukaro, Linda West, Conrad Brandt, Anne Maree Woollett, Michelle Edwards, Robert Spokes, Gregory Mitchell, Kimberley Prince, Theresa M Hayes, Ian CollinsIan Collins, Alexander David Guminski, Sally E Baron-Hay, Inger Helen Olesen, Jacinta Bryan, Susan Bowles, Shu Fen Wong, David M Ashley, Sujata Patil

Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).

History

Location

Chicago, IL

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036902249&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3.1 Extract of paper

Volume

33

Start date

2015-05-29

End date

2015-06-02

ISSN

0732-183X

eISSN

1527-7755

Title of proceedings

JOURNAL OF CLINICAL ONCOLOGY

Event

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology

Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).

History

Location

Language

Author URL

Publication classification

Volume

Start date

End date

ISSN

eISSN

Title of proceedings

Event

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports